✦ LIBER ✦

PMS22 COST-EFFECTIVENESS OF THE USE OF ETANERCEPT VS. RITUXIMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS IN MEXICO

✍ Scribed by X Gao; S Hwang; KT Carpiuc; JM Stephens; R Sato; A Singh; R Rivera; E García; H Bierschwale

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PMS22 COST-EFFECTIVENESS ANALYSIS OF ETA

✍ J. Vargas-Valencia; M. Sotelo-Guzmán; J.F. Mould-Quevedo; E. Muciño-Ortega; R.M. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

PMS5 COST-EFFECTIVENESS OF THE USE OF ET

✍ Aguirre, A; García, E; Bierschwale, H; Arce, CA 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB

PMS70 COST-EFFECTIVENESS OF ETANERCEPT V

✍ X Gao; S Hwang; KT Carpiuc; JM Stephens; R Sato; A Singh 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

Cost-effectiveness analysis of rituximab

✍ Sonja Merkesdal; Timm Kirchhoff; Diane Wolka; Gunter Ladinek; Adrian Kielhorn; A 📂 Article 📅 2009 🏛 Springer 🌐 French ⚖ 293 KB

PMS11 COST-EFFECTIVENESS ANALYSIS OF RIT

✍ SF Lou; DY Chen; TT Cheng; CM Huang; HY Lin; CC Su; WC Tsai; JC Tseng; CC Wei; L 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB

PMS21 COST—EFFECTIVENESS OF RITUXIMAB VS

✍ LA Bynum; N Joshi 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB